Gastroesophageal Junction Cancer
📧 Sign up to get email alerts when something new happens for Gastroesophageal Junction Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-10-31Clinical Trial Update: Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial tested the combination of docetaxel, 5-fluorouracil, and oxaliplatin in patients with gastric cancer or gastroeso…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma
Roche-sponsored clinical trial update on HER-2 status in gastric and gastroesophageal junction cancers; the study is completed and results w…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: PET/MR-imaging to Differentiate Between Responders and Non-responders Receiving Preoperative Chemotherapy
A completed clinical trial evaluated PET/MR imaging to differentiate responders from non-responders among patients receiving preoperative ch…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: Feasibility, Safety and QoL After Merendino Procedure
Completed clinical trial evaluating feasibility, safety, and quality of life after the Merendino procedure for distal esophagus or gastroeso…
-
CLINICAL_TRIALS trial_result · 2016-04-28Clinical Trial Update: Cetuximab and Radiation Therapy for Surgically Resectable Esophageal and Gastroesophageal (GE) Junction Carcinomas [Phase 2]
Phase 2 trial evaluating cetuximab with radiation therapy for surgically resectable esophageal and gastroesophageal junction carcinomas; res…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Pemetrexed, Cisplatin, and Radiation Therapy in Treating Patients With Esophageal or Gastroesophageal Junction Cancer [Phase 1]
A Phase 1 study evaluating pemetrexed in combination with cisplatin and radiation therapy for esophageal and gastroesophageal junction cance…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ [Phase 1]
Phase 1/1b trial of rilotumumab in Japanese patients with advanced solid tumors and advanced or metastatic gastric or GEJ cancer has complet…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial of ramucirumab in Japanese patients with metastatic gastric or gastroesophageal junction cancer has completed with results pos…
-
CLINICAL_TRIALS withdrawal · 2016-02-15Clinical Trial Update: Study of Epirubicin (Pharmorubicin®), Carboplatin (Paraplatin®) and Capecitabine (Xeloda®) (ECC) in the Treatment of Unresectable Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Cancer With Pharmacogenetic Correlates [Phase 1, Phase 2]
A phase 1/2 trial of Epirubicin (Pharmorubicin), Carboplatin (Paraplatin) and Capecitabine (Xeloda) for unresectable locally advanced or met…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Docetaxel+Oxali+/-Cetux Met Gastric/GEJ [Phase 2]
Phase 2 trial assessed docetaxel plus oxaliplatin, with or without cetuximab, in metastatic gastric/GEJ adenocarcinoma; results were posted …
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma [Phase 2]
Phase 2 trial assessing preoperative chemotherapy with bevacizumab and PET-guided salvage therapy in locally advanced but resectable gastric…
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin [Phase 2]
This Phase 2 trial evaluated the combination of cetuximab, cisplatin, and irinotecan in patients with metastatic esophageal cancer, gastroes…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy [Phase 2]
Phase 2 efficacy study results comparing ipilimumab to the standard of care after first-line chemotherapy in locally advanced unresectable o…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer [Phase 2]
Phase 2 trial evaluating nab-paclitaxel as salvage therapy in locally advanced or metastatic gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating radiotherapy and chemotherapy given before and after surgery for advanced esophageal or gastroesophageal j…
-
CLINICAL_TRIALS withdrawal · 2015-08-26Clinical Trial Update: huC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction Carcinomas [Phase 2]
This clinical trial update indicates that the Phase 2 study of huC242-DM4 for metastatic or locally advanced gastric and gastroesophageal ju…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
This is a Phase 2 trial update of the combination erlotinib and bevacizumab in patients with cancer of the esophagus or gastroesophageal jun…
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Significance of Peritoneal Washing Cytology Before and After Neoadjuvant Chemotherapy in Patients With Esophagogastric-junction Cancer
This completed trial update evaluates the significance of peritoneal washing cytology before and after neoadjuvant chemotherapy in patients …
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer [Phase 1]
Phase I trial of MT110 in multiple solid tumors has completed enrollment, evaluating MT110 in lung cancer (non-small cell and small cell), g…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating docetaxel with or without vandetanib in metastatic gastric cancer and gastroesophageal junction cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
This completed clinical trial updates the incidence and patterns of nausea and vomiting in patients treated with combined chemotherapy and r…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction [Phase 1, Phase 2]
Phase 1/2 trial evaluating neoadjuvant radiochemotherapy for adenocarcinoma at the gastroesophageal junction has completed, focusing on safe…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
Phase 2 trial evaluating sequence of combination chemotherapy followed by chemoradiotherapy with or without surgery for resectable locally a…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer [Phase 2]
Phase 2 trial evaluating AZD8931 in combination with paclitaxel versus paclitaxel alone in metastatic gastric/gastroesophageal junction canc…
-
CLINICAL_TRIALS withdrawal · 2014-08-01Clinical Trial Update: KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer [Phase 1]
This clinical trial update reports the withdrawal of a Phase 1 study evaluating KD019 in combination with Trastuzumab for esophageal, gastro…